home

Actelion ups outlook for 2016, reports Q1 net income up 12%

EVENTSpharmafile2016-04-25 15:05 Read   112

Swiss biotech company Actelion (VTX: ATLN) raised its outlook for 2016 and reported a 12% rise in first quarter net income.

Novartis' Entresto uptake better in EU as U.S. warms slowly to new heart meds

EVENTSfiercepharma2016-04-25 09:56 Read   82

Drugmakers generally expect to make most of their money on new drugs in the U.S., the world’s largest market with the most liberal payment system.

Novartis splits U.S. honcho's job in two as current chief Christi Shaw steps down

EVENTSfiercepharma2016-04-25 09:47 Read   242

Novartis will see a changing of the guard in the U.S. next week. Christi Shaw, who has headed up the Swiss drugmaker’s U.S. operations since April 2014, is stepping down for personal and family reasons, to be replaced by two current Novartis execs.

Medpace seeking $1B public offering: Reuters

EVENTSfiercebiotech2016-04-25 09:22 Read   83

Cincinnati CRO Medpace is looking to float for more than $1 billion, according to reports from Reuters quoting people “familiar with the matter.”

Sanofi signs cancer pact with Asian biotech Hummingbird

EVENTSfiercebiotech2016-04-25 09:17 Read   117

In the same week that Sanofi ($SNY) invested more heavily into its European biologics center, the French drugmaker has now agreed on a new cancer antibody pact in Asia with biotech Hummingbird Bioscience.

Aptuit announces acquisition of Exquiron Biotech AG

EVENTSexquiron2016-04-25 09:05 Read   74

LLC today announced that it has acquired Exquiron Biotech AG to meet customer demand for fully integrated outsourced discovery services.

Petnostics Wins on "Shark Tank"

EVENTSprweb2016-04-22 11:23 Read   117

On Friday, April 15, 2016, Petnostics founder Stephen Chen appeared on ABC’s "Shark Tank" seeking $300,000 in exchange for 10% equity in his company to aid the development of additional pet health products and expand the company’s retail presence nationwide. Impressed by his pitch, and Petnostics’ patented pet health technology, Lori Greiner and Kevin O'Leary paired up to offer Stephen $300,000 for 20% equity in the company.

Glaxo balks at U.K.'s $54M pay-for-delay fine

EVENTSfiercepharma2016-04-22 11:14 Read   100

GlaxoSmithKline’s U.K. offices have taken exception to a major multimillion-pound fine levied by the country’s market watchdog, saying its conduct was “objectively justified.”

‘Toxic compound’ gains final blame in French trial disaster

EVENTSfiercebiotech2016-04-22 09:37 Read   88

The final regulatory report into a fatal French drug trial run by a drugmaker and its CRO partner earlier this year was "clearly linked to the compound tested"--but the report’s lead author claims common sense was lacking from researchers.

Allergan Acquires Topical Dermatology Company Topokine Therapeutics Adding Non-Invasive Fat Reduction Development Program

EVENTSprnewswire2016-04-22 09:31 Read   198

Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has acquired Topokine Therapeutics, a privately held, clinical-stage biotechnology company focused on developing topical medicines for fat reduction.

Experts Discuss the Latest Trends in HBV

EVENTShealio2016-04-21 15:30 Read   90

While hepatitis B virus continues to be a major global health problem, incidence in the U.S. has significantly declined since the introduction of the universal vaccine in the 1990s.

Boehringer Ingelheim charts strong growth in livestock meds ahead of Merial union

EVENTSfiercepharma2016-04-21 14:39 Read   299

Pharma giant Boehringer Ingelheim, which is in the process of merging its Vetmedica unit with Sanofi’s ($SNY) Merial division, reported strong results in animal health for 2015